Retrospective analysis of the risk of hyperkalaemia in women older than 65 years of age prescribed spironolactone for female-pattern hair loss

Br J Dermatol. 2023 Feb 22;188(3):429-447. doi: 10.1093/bjd/ljac068.

Authors

Maya S Collins¹, Shaheir Ali¹, Isabel P Wiss¹, Maryanne M Senna^{1

2}

Affiliations

¹ Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.
² Lahey Hospital & Medical Center Department of Dermatology, Burlington, MA, USA.

PMID: 36634081
DOI: 10.1093/bjd/ljac068

No abstract available

MeSH terms

Alopecia / drug therapy
Drug Therapy, Combination
Female
Humans
Hyperkalemia*
Retrospective Studies
Spironolactone* / therapeutic use

Substances

Spironolactone